Search results for "VTE"
Intervention in safety-net system failed to reduce overuse of VTE prophylaxis
An order set and best practice advisory in the electronic health record did not significantly affect use of prophylaxis against venous thromboembolism (VTE), but did provide some useful lessons, a study of 11 New York City hospitals found.
https://acphospitalist.acponline.org/archives/2023/04/19/intervention-in-safety-net-system-failed-to-reduce-overuse-of-vte-prophylaxis.htm
19 Apr 2023
Simple steps for sounder sleep
New protocols for blood pressure checks and clot prophylaxis allowed patients to get better sleep at one hospital.
https://acphospitalist.acponline.org/archives/2023/03/22/simple-steps-for-sounder-sleep.htm
22 Mar 2023
Tocilizumab approved for COVID-19
The FDA gave full approval to tocilizumab for adults with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, noninvasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation, among other actions.
https://acphospitalist.acponline.org/archives/2023/01/25/tocilizumab-approved-for-covid-19.htm
25 Jan 2023
Aspirin noninferior to LMWH for prophylaxis after traumatic fractures, trial finds
All-cause mortality at 90 days was similar in hospitalized patients randomized to aspirin versus low-molecular-weight heparin (LMWH), and rates of deep venous thrombosis and pulmonary embolism were also low in both groups.
https://acphospitalist.acponline.org/archives/2023/01/25/aspirin-noninferior-to-lmwh-for-prophylaxis-after-traumatic-fractures-trial-finds.htm
25 Jan 2023
New studies assess effects of anticoagulation during, after COVID-19
Use of intermediate, full-dose, or prophylactic anticoagulation in COVID-19 inpatients wasn't associated with any difference in in-hospital mortality in one study, while another found it was safe to discontinue anticoagulation after three months in patients with a COVID-19-associated clot.
https://acphospitalist.acponline.org/archives/2022/11/16/free/new-studies-assess-effects-of-anticoagulation-during-after-covid-19.htm
16 Nov 2022
Rivaroxaban for 45 days after discharge reduced nonfatal VTEs, industry study finds
The tradeoff for the 26 fewer venous thromboembolisms (VTEs) among 10,000 recently hospitalized patients would be eight additional major bleeds, according to the new analysis of a placebo-controlled randomized trial.
https://acphospitalist.acponline.org/archives/2022/10/19/rivaroxaban-for-45-days-after-discharge-reduced-nonfatal-vtes-industry-study-finds.htm
19 Oct 2022
Harm during hospitalization more common in patients with developmental disability
Hospitalized patients with intellectual disability, chromosomal abnormalities, pervasive developmental disorders, and congenital malformation syndrome had a 2.7-fold higher risk of an avoidable patient safety incident than those without developmental disability, according to an analysis in England.
https://acphospitalist.acponline.org/archives/2022/10/12/harm-during-hospitalization-more-common-in-patients-with-developmental-disability.htm
12 Oct 2022
COVID-19 hospitalization carries higher VTE risk than flu regardless of vaccination status
The 90-day absolute risk of venous thromboembolism (VTE) was 5.3% in patients hospitalized with influenza compared to 9.5% in COVID-19 patients hospitalized before vaccine availability and 10.9% in patients with COVID-19 after vaccines became available, a study found.
https://acphospitalist.acponline.org/archives/2022/08/24/free/covid-19-hospitalization-carries-higher-vte-risk-than-flu-regardless-of-vaccination-status.htm
24 Aug 2022
Apixaban associated with less bleeding than warfarin for VTE in end-stage kidney disease
The use of apixaban among dialysis patients being treated for acute venous thromboembolism (VTE) rose from 2% in 2014 to 47% in 2018, according to an industry-funded retrospective comparison of the drug with warfarin.
https://acphospitalist.acponline.org/archives/2022/08/17/apixaban-associated-with-less-bleeding-than-warfarin.htm
17 Aug 2022
Latest COVID-19 research looks at lung ultrasound, CVST and VTE risk, visitation policies
Recent studies offered a new method for using lung ultrasound to assess COVID-19 patients, assessed risk of central venous sinus thrombosis (CVST), and looked at a lab test to help predict venous thromboembolism (VTE) and at the effects of restricting visitors.
https://acphospitalist.acponline.org/archives/2022/08/10/free/latest-covid-19-research-looks-at-lung-ultrasound-cvst-and-vte-risk-visitation-policies.htm
10 Aug 2022